Document:

AXM Pharma, Inc. Exhibit 10.14 

Exhibit 10.14

CONSULTING AGREEMENT

          

THIS AGREEMENT (the “Agreement”), is made and entered into as of this 10th  day of September, 2004, by and between Mirador Consulting, Inc., a Florida corporation, with offices at 5499 N. Federal Hwy, Suite D, Boca Raton, Florida 33487 (“Mirador” or the “Consultant”), and AXM Pharma, Inc., a Nevada corporation, with offices at 8324 Delgany Avenue, Playa del Rey, CA 90293 (the “Company”) (together the “Parties”).

WHEREAS, Consultant is in the business of providing services for management consulting, business advisory, shareholder information and investor relations; 

WHEREAS, the Company deems it to be in its best interest to retain Consultant to render to the Company such services as may be needed; and

WHEREAS, the Parties desire to set forth the terms and conditions under which Consultant shall provide services to the Company.

NOW, THEREFORE, in consideration of the mutual promises and covenants herein contained, and other valid consideration, receipt of which is hereby acknowledged, the Parties agree as follows:

Term of Agreement

The Agreement shall remain in effect from the date hereof through the expiration of a period of three months from the date hereof (the “Term”), and thereafter may be renewed upon the mutual written consent of the Parties.  

Nature of Services to be rendered.

During the Term and any renewal thereof, Consultant shall: (a) provide the Company with corporate consulting services on a best efforts basis in connection with mergers and acquisitions, corporate finance, corporate finance relations, introductions to other financial relations companies and other financial services; (b) use its best efforts to respond to questions from the Company’s existing stockholders in a professional manner and follow up as appropriate; and (c) use its best efforts to introduce the Company to various securities dealers, investment advisors, analysts, funding sources and other members of the financial community with whom it has established relationships, and generally assist the Company in its efforts to enhance its visibility in the financial community (collectively, the “Services”).

It is acknowledged and agreed by the Company that Consultant carries no professional licenses, and is not rendering legal advice or performing accounting services, nor acting as an investment advisor or broker/dealer within the meaning of the applicable state and federal securities laws.  The Services of Consultant shall not be exclusive nor shall Consultant be required to render any specific number of hours or assign specific personnel to the Company or its projects.

1

__________________________________________________________________________________

Consulting Agreement for AXM Pharma, Inc.

Disclosure of Information

Consultant agrees as follows:

The Consultant shall NOT disclose to any third party any material non-public information or data received from the Company without the written consent and approval of the Company other than: (i) to its agents or representatives that have a need to know in connection with the Services hereunder; provided such agents and representatives have a similar obligation to maintain the confidentiality of such information; (ii) as may be required by applicable law; provided, Consultant shall provide prompt prior written notice thereof to the Company to enable the Company to seek a protective order or otherwise prevent such disclosure; and (iii) such information as becomes publicly known through no action of the Consultant, or its agents or representatives.

Following receipt of written notice from the Company of a filing in connection with a proposed public offering of the securities of the Company, and until the Company informs the Consultant that such offering has been completed or has terminated, the Consultant shall not engage in any public relations efforts on behalf of the Company without approval of counsel for the Company and counsel for the underwriter(s), if any.

Compensation.

The following represents the compensation to be received by the Consultant in connection with rendering the Services hereunder:

 

Upon execution of the Agreement, the Company will issue to the Consultant 30,000 shares of the Company’s restricted common stock (AMEX: AXJ) (the “Restricted Stock”).

During the Term of this Agreement, the Company will reimburse the Consultant the sum of two thousand ($2,000.00) dollars per month for expenses; provided, however that such payment for the first month shall be due and payable upon the execution of this Agreement. 

Representations and Warranties of the Consultant.

         

In order to induce the Company to enter into this Agreement, the Consultant hereby makes the following unconditional representations and warranties:

In connection with its execution of and performance under this Agreement, the Consultant has not taken and will not take any action that will cause it to become required to make any filings with or to register in any capacity with the Securities and Exchange Commission (the “SEC”), the National Association of Securities Dealers, Inc. (the “NASD”), the securities commissioner or department of any state, or any other regulatory or governmental body or agency.

Consultant agrees that it will only communicate regarding The Company to licensed brokerage professionals and will not engage in any solicitation of the public with regard to The Company or its securities.  Notwithstanding the foregoing, Consultant may provide approved information regarding the Company (i) in response to unsolicited inquiries by the Company’s shareholders; (ii) to valid trade and industry publications, newspapers and periodicals; and (iii) otherwise engage in communications which are normal and customary for an investor relations firm and 

2

__________________________________________________________________________________

Consulting Agreement for AXM Pharma, Inc.

which do not involve solicitation of investors in connection with its role as an investor relations firm for the Company.  Consultant further agrees that it will only disclose information specifically provided to it by the Company regarding The Company for dissemination and will keep confidential any information marked as such by The Company.  Consultant agrees that it will not make any undisclosed payments to brokers or others and will generally act within the letter and the spirit of U.S. securities laws, rules and regulations at all times.

Neither the Consultant nor any of its principals is subject to any sanction or restriction imposed by the SEC, the NASD, any state securities commission or department, or any other regulatory or governmental body or agency, which would prohibit, limit or curtail the Consultant’s execution of this Agreement or the performance of its obligation hereunder. The Consultant is permitted to provide consulting services to any corporation or entity engaged in a business identical or similar to the Company’s. 

Consultant shall provide a detailed written report regarding its activities to the Company on a quarterly basis.  Such written report shall detail who the Consultant has communicated about the Company to, the type of communications/meetings, any research coverage initiated, log of conference calls you set up management and shall contain a written affirmation from the Consultant that it is in compliance with the terms of this Agreement on the date of such report.

Duties of the Company    

The Company will supply Consultant, on a regular basis and timely basis, with all approved data and information about the Company, its management, its products, and its operations as reasonably requested by Consultant and which the Company can obtain with reasonable effort; and Company shall be responsible for advising Consultant of any facts which would affect the accuracy of any prior data and information previously supplied to Consultant so that the Consultant may take corrective action.

The Company shall promptly supply Consultant with full and complete copies of all filings with all federal and state securities agencies; with full and complete copies of all stockholder reports and communications whether or not prepared with the assistance of Consultant; with all data and information supplied to any analyst, broker-dealer, market maker, or other member of the financial community and with all product/services brochures, sales materials, etc. filed or prepared by the Company after the date of this Agreement.  Company shall supply to Consultant, within 15 days of execution of this Agreement, with a list of all stockbrokers and market makers active in the stock of Company, and a complete list of all shareholders.

The Company’s counsel must, within five (5) business days of receiving written notice from the Consultant, provide an opinion letter to the Consultant and the Transfer Agent for the Company’s Restricted Stock addressing the permissible resale of the Restricted Stock (pursuant to Rule 144 of the Securities Act of 1933, as amended (the “1933 Act”) transferred to the Consultant under this Agreement; provided, however, that such a opinion letter will not be issued prospectively but will only be provided by counsel upon reasonable evidence that the holding period specified in Rule 144(d) has been satisfied and that Consultant and the Company are in full compliance with such other and further requirements as are then specified in Rule 144 for resales made in reliance  on such rule.

  

Representations and Warranties of the Company.

3

__________________________________________________________________________________

Consulting Agreement for AXM Pharma, Inc.

                        

In order to induce the Consultant to enter into this Agreement, the Company hereby makes the following unconditional representations and warranties:

The Company is not subject to any restriction imposed by the SEC or by operation of the 1933 Act, the Exchange Act of 1934, as amended (the “1934 Act”) or any of the rules and regulations promulgated under the 1933 Act or the 1934 Act which prohibit its execution of this Agreement or the performance of its obligations to the Consultant set forth herein.

The Company has not been sanctioned by the SEC, the NASD or any state securities commissioner or department in connection with any issuance of its securities.  All payments required to be made on time and in accordance with the payment terms and conditions set forth herein.

Compliance with Securities Laws

The Parties acknowledge and agree that the Company is subject to the requirements of the 1934 Act, and that the 1933 Act, the 1934 Act, the rules and regulations promulgated thereunder and the various state securities laws (collectively, “Securities Laws”) impose significant burdens and limitations on the dissemination of certain information about the Company by the Company and by persons acting for or on behalf of the Company.  Each of the Parties agrees to comply with all applicable Securities Laws in carrying out its obligations under the Agreement; and without limiting the generality of the foregoing, the Company hereby agrees (i) all information about the Company provided to the Consultant by the Company, which the Company expressly agrees may 

be disseminated to the public by the Consultant in providing any public relations or other services pursuant to the Agreement, shall not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements made, in light of the circumstances in which they were made, not misleading, (ii) the Company shall promptly notify the Consultant if it becomes aware that it has publicly made any untrue statement of a material fact regarding the Company or has omitted to state any material fact necessary to make the public statements made by the Company, in light of the circumstances in which they were made, not misleading, and (iii) the Company shall promptly notify the Consultant of any “quiet period” or “blackout period” or other similar period during which public statements by or on behalf of the Company are restricted by any Securities Law.  Each Party (an “indemnifying party”) hereby agrees, to the full extent permitted by applicable law, to indemnify and hold harmless the other Party (the “indemnified party”) for any damages caused to the indemnified party by the indemnifying party’s breach or violation of any Securities Law, except to the extent that the indemnifying party’s breach or violation of a Securities Law is caused by the indemnified party’s breach or violation of the Agreement, or any Securities Law.

Issuance of Restricted Stock to Consultant

The Restricted Stock shall be issued as fully-paid and non-assessable securities. The Company shall take all corporate action necessary for the issuance Restricted Stock, to be legally valid and irrevocable, including obtaining the prior approval of its Board of Directors.

Expense Reimbursement.

Consultant shall be entitled to receive cash reimbursement, and the Company shall provide cash reimbursement, of all reasonable and necessary cash expenses paid by the Consultant on behalf 

4

__________________________________________________________________________________

Consulting Agreement for AXM Pharma, Inc.

of the Company in performance of its own duties hereunder. Such expenses shall include, without limitation, reasonable expenses for communications, deliveries and travel. In no event, however, will the Consultant incur on behalf of the Company any expense without the prior written consent of the Company.

Registration Obligations.

  

At any time following the signing of the Agreement if the Company files a registration statement with the SEC registering an amount of securities equal to at least $500,000 (“Registration Statement”), the Company must provide a ten (10) day prior written notice of the Registration Statement to the Consultant and any subsequent holder of the Restricted Stock and at the written request and direction of the Consultant and/or subsequent holders must provide piggy back registration rights and include the consultant and/or subsequent holders shares in the Registration Statement.  Provided, however, that should the Company engage in an underwritten public offering of its securities, the Restricted Stock held by the Consultant shall be subject to any limitations or cutbacks reasonably requested by the underwriter, pro-rata with any other selling shareholders who may have similar rights.

Indemnification of Consultant by the Company.

The Company acknowledges that the Consultant relies on information provided by the Company in connection with the provisions of Services hereunder and represents that said information does not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements made, in light of the circumstances in which they were made, not misleading, and agrees to hold harmless and indemnify the Consultant for claims against the Consultant as a result of any breach of such representation and for any claims relating to the purchase and/or sale of the Company’s securities occurring out of or in connection with the Consultant’s relationship with the Company including, without limitation, reasonable attorney’s fees and other costs arising out of any such claims; provided, however, that the Company will not be liable in any such case for losses, claims, damages, liabilities or expenses that arise from the gross negligence or willful misconduct of Consultant. 

Indemnification of the Company by the Consultant.

The Consultant shall identify and hold harmless the Company and its principals from and against any and all liabilities and damages arising out of any the Consultant’s gross negligence or intentional breach of its representations, warranties or agreements made hereunder.  

Applicable Law.

It is the intention of the parties hereto that this Agreement and the performance hereunder and all suits and special proceedings hereunder be construed in accordance with and under and pursuant to the laws of the State of Florida and that in any action, special proceeding or other proceedings that may be brought arising out of, in connection with or by reason of this Agreement, the law of the State of Florida shall be applicable and shall govern to the exclusion of the law of any other forum, without regard to the jurisdiction on which any action or special proceeding may be instituted.  

5

__________________________________________________________________________________

Consulting Agreement for AXM Pharma, Inc.

Legal Disputes.

Any and all conflicts, disputes and disagreements arising out of or in connection with any aspect of the Agreement shall be subject to the jurisdiction of state court, Palm Beach County, Florida. 

 

Attorney Fees.

In the event a legal action is commenced by a Party to the Agreement alleging a default of the terms or conditions of the Agreement and judgment is held, the prevailing party shall be entitled to recover all costs incurred as a result of such action including reasonable attorney fees, expenses and court costs through trial, appeal and to final disposition.

 Entire Understanding/Incorporation of other Documents.

The Agreement contains the entire understanding of the Parties with regard to the subject matter hereof, superseding any and all prior agreements or understandings whether oral or written, and no further or additional agreements, promises, representations or covenants may be inferred or construed to exist between the Parties.

No Assignment or Delegation Without Prior Approval.

No portion of the Agreement or any of its provisions may be assigned, nor obligations delegated, to any other person or party without the prior written consent of the Parties except by operation of law or as otherwise set forth herein.

Survival of Agreement.

The Agreement and all of its terms shall inure to the benefit of any permitted assignees of or lawful successors to either Party.

Independent Contractor.

Consultant agrees to perform its consulting duties hereto as an independent contractor.  Nothing contained herein shall be considered to as creating an employer-employee relationship between the parties to this Agreement.

No Amendment Except in Writing.

Neither the Agreement nor any of its provisions may be altered or amended except in a dated writing signed by the Parties.

Waiver of Breach.

 No waiver of any breach of any provision hereof shall be deemed to constitute a continuing waiver or a waiver of any other portion of the Agreement.

6

__________________________________________________________________________________

Consulting Agreement for AXM Pharma, Inc.

Severability of the Agreement.

Except as otherwise provided herein, if any provision hereof is deemed by arbitration or a court of competent jurisdiction to be legally unenforceable or void, such provision shall be stricken from the Agreement and the remainder hereof shall remain in full force and effect.

Termination of the Agreement. 

Either Party may terminate the Agreement, with or without cause, by providing a thirty (30) day written notification to the other Party. The Agreement will terminate thirty (30) days following the date of receipt of the written notification by the non-terminating party (“Date of Termination”).  In the event of termination of the Agreement by the Company, the Consultant shall be entitled to keep any and all fees, Company stock or other compensation it received from the Company under the Agreement prior to the Date of Termination. 

Counterparts and Facsimile Signature.

This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which taken together shall constitute one and the same instrument.  Execution and delivery of this Agreement by exchange of facsimile copies bearing the facsimile signature of a party hereto shall constitute a valid and binding execution and delivery of this Agreement by such party.  Such facsimile copies shall constitute enforceable original documents.

No Construction Against Drafter.

The Agreement shall be construed without regard to any presumption or other requiring construction against the Party causing the drafting hereof.

      

   IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement, effective as of the date set forth above.

.

          AXM Pharma, Inc.

           Mirador Consulting, Inc.

    

             By: _______________________  

  By: ____________________________

                  Peter Cunningham, CEO                              

  Brian S. John, President

7

__________________________________________________________________________________

Consulting Agreement for AXM Pharma, Inc.AXM Pharma, Inc. EXhibit 10.15

Exhibit 10.15

Dreamvest, llc

417 ORCHID AVE. CORONA DEL MAR, CA 92625

800-715-9999 ph 815-328-0698 fax

CONSULTING AGREEMENT

This Consulting Agreement (“Agreement”) is to be effective as of September 1, 2004, entered into by and between AXM Pharma, Inc. (“Company”), with offices located at 4695 MacArthur Ct. Newport Beach, CA  92660 and Dreamvest, LLC  (“Consultant”), having offices at 417 Orchid Ave, Corona Del Mar, CA  92625.

For the purposes of this Agreement, either of the above shall be referred to as a “Party” and collectively as the “Parties”. 

The Parties hereby agree as follows: 

FACT RECITALS. 

The general purpose for this Agreement is for Company to engage the services of Consultant and for Consultant to perform such services for and behalf of Company as set forth herein. Company will, at all times, cooperate with Consultant in carrying out the purpose of this Agreement, and keep Consultant informed of any developments of importance and material impact pertaining to Company’s business and abide by this Agreement in its entirety. 

1.

APPOINTMENT OF DREAMVEST, LLC.  Company hereby appoints Consultant and Consultant hereby agrees to render services to Company as research analyst for key industry statistics, institutional and financial information, and  potential acquisition targets.

2.

SCOPE AND DELIVERABLES. During the term of this Agreement, Consultant shall provide Company with the following deliverables: 

a.

News dissemination via mail and email, research analyst for key industry statistics, institutional and financial information , research and introductions to potential funding sources. 

Consultant will provide these deliverables on an ongoing basis over the entirety of the lifetime of this Agreement. 

3.

TERM. The term (“Term”) of this Consulting Agreement shall be for a period of 12 months. 

4.

COMPENSATION. Company agrees to compensate Consultant with stock options for 100,000 shares of the common stock of AXM Pharma, Inc. (AMEX:  AXJ) exercisable at current market price as the date of this agreement per share with a 5  year expiration.  The options shall vest immediately and be registered for sale in the public markets at the next registration where insider’s options are registered.  Option agreement will be delivered to Consultant promptly following the execution of this agreement.

5.

INDEMNIFICATION. Company, its agents or assigns hereby agree to indemnify and hold Consultant harmless from and against all losses, claims, damages, liabilities, costs or expenses (including reasonable attorney’s fees, collectively the “Liabilities”), joint and several, arising from the performance of this Consulting Agreement, whether or not Consultant is party to such dispute. This indemnity shall not apply, however, and Consultant shall indemnify and hold company, its affiliates, control persons, officers, employees and agents harmless from and against all liabilities, where a court of competent jurisdiction has made a final determination that Consultant engaged in gross negligence,  recklessness or willful misconduct in the performance of its services hereunder, which have given rise to the loss, claim, damage, liability, cost or expense sought to be recovered hereunder (but pending any such final determinations, the indemnification and reimbursement provision of this Consulting Agreement shall apply and Company shall perform its obligation hereunder to reimburse Consultant for its expenses). 

6.

DISCLOSURE. Consultant will fully disclose, as required by applicable state and federal securities laws, all compensation (whether cash, stock, options, warrants or other considerations) received from the Company pursuant to this agreement and any other agreements with Consultant or any affiliated companies in any research reports or other information provided to the public on behalf of the Company.

7.

INDEPENDENT CONTRACTOR. Consultant and Company hereby acknowledges that Consultant is an independent contractor. Consultant shall not hold itself out, as, nor shall it take any action from which others might infer that it is an agent of or a joint venture of Company. 

8.

PARTIAL INVALIDITY. If any part of this agreement shall be deemed by a court or mediator to be invalid, the remainder hereof shall be construed as if the invalid portion has been omitted. 

9.

WAIVER. No waiver of any of the provisions of this agreement shall be deemed or shall constitute a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver. No waiver shall be binding unless executed in writing by the party making the waiver. 

10.

TERMINATION. Any termination of this Agreement by the Company shall not affect or limit (i) the rights of Consultant to receive indemnification, (ii) rights to receive fees accrued prior to such termination (iii) rights to receive fees and be covenanted to all the terms and conditions detailed in this Letter Agreement on any financing that was negotiated during the terms of this Letter. 

11.

LAW GOVERNING AGREEMENT. This agreement shall be governed by and construed in accordance with the laws of California. 

12.

MISCELLANEOUS. This Consulting Agreement sets forth the entire understanding of the Parties relating to the subject matter hereof and supercedes and cancels any prior communications, understandings and agreements between the Parties. This Consulting Agreement is non-exclusive and cannot be modified or changed, nor can any of its provisions be waived, except by written agreement by all Parties. In the event of any dispute s to the Terms of this Consulting Agreement, the prevailing Party in any litigation shall be entitled to reasonable attorney’s fees. 

13.

NOTICES. Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein) and shall be deemed effectively given upon personal delivery or seven business days after deposit in the United States Postal Service, by (a) advance copy by fax, (b) mailing by express courier or registered or certified mail with postage and fees prepaid, addressed to each of the other Parties thereunto entitled at the following addresses, or at such other addresses as a Party may designate by ten (10) days advance written to each of the other Parties hereto: 

Company: 

AXM Pharma, Inc.

4695 MacArthur Ct.

Newport Beach, CA  92660 

Attn: Peter Cunningham

Email:  pcunningham@axmpharma.com

Consultant: Dreamvest, LLC

417 Orchid Ave.

Corona Del Mar, CA  92625

Attn:  Tom Ronk

Email:  tronk@adelphia.net

16. ENTIRE AGREEEMENT.  All parties to this agreement must sign any modifications to this agreement. 

With my hand below I affirm that I am legally authorized signatory for this transaction, empowered to bind myself and/or my company to legal agreements by this signature. In so doing I attest that I fully understand the foregoing statement(s) contained in this Agreement and accept the percentages without reservation or modification. 

Accepted and agreed to as of this 1st day of September 2004. 

AXM Pharma, Inc.   

              Dreamvest, LLC

 

Peter Cunningham

Thomas Ronk

Chief Executive Officer

               Managing Member

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]